A Systematic Review of Longitudinal Studies Measuring Alzheimer’s Disease Biomarkers

Manuscript Number: 

17-0261R2

Author(s): 
Roy M. Anderson, Frank De Wolf, Christoforos Hadjichrysanthou, Emma Lawrence, Alison Ower, Carolin Vegvari

Disclosures

Roy M. Anderson

  • Consulting Fees:
    VACIAB - Vaccine company in Malaysia - 2014 - present PTTGC Thailand Oil and Gas Company - Chair International Advisory Board
    Equity:
    GlaxoSmithKline 25,500 shares held as a Non Executive Director
    Grants
    • Agency: 
      Jansen - work on clinical trial simulators
      Dates: 
      2014-17
    • Agency: 
      GlaxoSmithKline - work on Antibiotic Resistance
      Dates: 
      June 2017-20
    • Agency: 
      Menarini - work on Pneumococcal vaccines
      Dates: 
      2017

Frank De Wolf

  • Sponsors:
    I'm heading the Janssen Prevention Center in Leiden, The Netherlands.

Christoforos Hadjichrysanthou

  • Nothing to Disclose

Emma Lawrence

  • Nothing to Disclose

Alison Ower

  • Nothing to Disclose

Carolin Vegvari

  • Nothing to Disclose